Key Highlights
- Board member Kathryn K. Chou offloaded 2,757 shares of IonQ stock on June 18, generating proceeds of $151,690 at a weighted average of $55.02 per share
- John W. Raymond, another company insider, liquidated 3,815 shares on the identical date for $209,863
- IONQ shares are currently priced at $58.32, reflecting a 42% gain over the trailing twelve months, with the company valued at $21.79 billion
- Rockefeller Capital Management expanded its IONQ holdings by 257.1% during the fourth quarter, joining Vanguard, Norges Bank, and State Street in accumulating shares
- First quarter fiscal 2026 revenue reached $64.7 million, significantly exceeding the $49.75 million consensus projection, representing 754.7% annual growth
Shares of IonQ (IONQ) stock are changing hands at $58.32, posting a 42% advance over the previous twelve-month period, even as two executives divested shares last week amid continued accumulation by prominent institutional players.
Board Director Kathryn K. Chou executed a sale of 2,757 shares on June 18, 2026, at a weighted average of $55.02 per share, realizing total proceeds of $151,690. The transactions occurred at prices between $53.80 and $56.53. After completing this sale, Chou maintains ownership of 62,608 shares in the quantum computing company.
The divestiture followed her acquisition of 4,526 shares via a restricted stock unit grant on June 17. These RSU awards are scheduled to vest on whichever date arrives first: the day preceding the company’s next Annual Shareholder Meeting or June 17, 2027.
Chou’s transaction was conducted through a predetermined Rule 10b5-1 trading arrangement, which she established on September 11, 2025.
Concurrently, executive John W. Raymond disposed of 3,815 shares at an average execution price of $55.01, generating $209,863 in total value. His direct ownership now stands at 80,148 shares. Throughout the most recent 90-day period, company insiders have collectively sold 10,345 shares valued at $549,826.
Major Institutions Accumulate Shares
While executives were reducing positions, large-scale institutional capital flowed in the opposite direction. Rockefeller Capital Management expanded its IonQ investment by 257.1% during the fourth quarter, bringing its total to 511,178 shares worth approximately $22.9 million.
Vanguard expanded its ownership by 18.5% to 34,774,743 shares, representing more than $1.56 billion in value. Norges Bank established a fresh position valued at roughly $199.8 million. State Street boosted its allocation by 42.3%, while Marex Group dramatically increased its stake by 419.1%. Institutional shareholders collectively control 41.42% of IonQ’s outstanding shares.
IONQ began Tuesday’s session at $58.36. The shares have fluctuated within a 12-month band of $25.89 to $84.64. The 50-day simple moving average stands at $53.61, while the 200-day moving average rests at $45.04.
IonQ’s first quarter fiscal 2026 financial results featured revenue of $64.67 million, substantially surpassing Wall Street’s consensus projection of $49.75 million. This represents a remarkable 754.7% increase compared to the year-ago period. Management also elevated its full-year revenue outlook.
Earnings per share registered at -$0.34, falling short of the anticipated -$0.26. Sell-side analysts currently project -$2.26 EPS for the complete fiscal year.
Wall Street Price Targets and Ratings Overview
Northland Securities recently elevated its price objective on IonQ from $55 to $70, maintaining an outperform recommendation. Morgan Stanley established a target of $48.50. JPMorgan lifted its target from $42 to $50 while maintaining a neutral stance. DA Davidson reduced its target from $55 to $35, also with a neutral rating.
Among the 17 analysts providing coverage on the stock, 10 recommend buying, six suggest holding, and one advises selling. The consensus price target averages $69.88.
IonQ recently unveiled its Clavis XG Multiplex solution, a quantum security platform enabling simultaneous transmission of quantum and classical data over shared fiber infrastructure. Reports indicate the Trump administration is preparing executive directives aimed at accelerating quantum computing advancement.
Wall Street Zen modified IonQ’s rating from strong sell to sell on June 13. Zacks Investment Research has similarly raised valuation-related concerns.
